The Advance Biotech Grant Program recognizes emerging biopharmaceutical and biotech start-ups worldwide. It awards recipients with products, services, and consultation to advance production and accelerate commercialization. Applicants must describe their therapeutic focus, clinical strategy, and how the program can help overcome challenges and expertise gaps to bring innovations to market.
Eligible applicants include biopharmaceutical and biotech start-ups, entrepreneurs, scientists, and students. The program targets emerging companies and individuals involved in biotech innovation.
